Related Experiment Video
Updated: May 15, 2026
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
[The application of laripront in the pediatric otorhinolaryngological practice]
Insights
Laripront effectively treated pediatric inflammatory laryngopharyngeal diseases, showing positive outcomes in all patients, particularly those with acute conditions. No adverse effects were observed during this study.
Area of Science:
- Otolaryngology
- Pediatric Medicine
- Pharmacology
Context:
- Inflammatory diseases of the laryngopharynx are common in children.
- Existing treatments may have limitations or side effects.
- Need for effective and safe therapeutic options for pediatric ENT conditions.
Purpose:
- To evaluate the efficacy of laripront in treating pediatric inflammatory laryngopharyngeal diseases.
- To assess the safety profile of laripront in the pediatric population.
Summary:
- A study involving 50 pediatric patients (ages 4-14) with various ENT pathologies, including adenoiditis, tonsillitis, laryngitis, and pharyngitis, was conducted.
- Patients received laripront for treatment, with all participants showing positive treatment outcomes.
- The treatment was particularly effective in cases of acute inflammatory conditions, and no adverse effects were reported.
Impact:
- Laripront demonstrates significant therapeutic potential for a range of pediatric inflammatory laryngopharyngeal conditions.
- The favorable safety profile suggests laripront as a viable treatment option for children.
- Highlights the drug's efficacy in acute settings, potentially reducing treatment duration and improving patient recovery.
Abstract:
The objective of the present study was to estimate the efficacy of laripront intended for the treatment of inflammatory diseases of the laryngopharynx in the children. Available for the observation were 50 patients aged between 4 and 14 years suffering from the following ENT pathologies: adenoiditis, lacunar tonsillitis, acute laryngitis, chronic tonsillitis, oropharyngeal candidiasis, chronic hypertrophic pharyngitis, atrophic pharyngolaryngitis after the chemical burn of the mouse cavity and laryngopharynx or in the case of gastroesophageal reflux disease. All the patients enjoyed the positive outcome of the treatment that was especially efficacions in the patients with acute pathologies. No adverse effects of the treatment were documented.
